The International URBAN Alcohol Research Collaboration on HIV/AIDS (ARCH) Center, funded by the National Institute on Alcohol Abuse and Alcoholism, conducts and disseminates interdisciplinary research on the role of alcohol use among people with HIV on new tuberculosis (TB) acquisition, occurrence of active TB disease after TB preventive therapy, and post-TB lung disease.


Check out the latest issue of the quarterly URBAN ARCH Newsletter!

New Publication: Provider-patient experiences and HIV care utilization among people living with HIV who inject drugs in St. Petersburg, Russia. (Raj et al. 2023, Int J Qual Health Care)

New Publication: Rapid access to antiretroviral therapy, receipt of naltrexone, and strengths-based case management versus standard of care for HIV viral load suppression in people with HIV who inject drugs in Russia (LINC-II): an open-label, randomised controlled trial. (Samet et al. 2023, Lancet HIV)

New Publication: Safety and tolerability of isoniazid preventive therapy for tuberculosis for persons with HIV with and without alcohol use. (Hahn et al. 2023, AIDS)

New Publication: Cannabis use frequency and pain interference among people with HIV. (Klepp et al. 2023, AIDS Care)

New Publication: The impacts of COVID-19 on structural inequities faced by people living with HIV who inject drugs: A qualitative study in St. Petersburg, Russia. (Carroll et al. 2023, Int J Drug Policy)

For quarterly updates from URBAN ARCH, click here to join our newsletter list!